|Confidential Expert Witness Report Documents Psychiatrists' Corrupt Practices|| || |
|Wednesday, 15 June 2011|
The case filed against Johnson & Johnson by Allen Jones and the State of Texas was recently postponed until November. But some of the documents from the case are now publicly available at the Travis County, Texas courthouse.
The confidential Expert Witness Report by Dr. David Rothman of Columbia University (March 22, 2011), is the most damning document that we've seen in which not only is J & J's "detestable" conduct--as described by Judge Couch who presided over the court decision against J & J in South Carolina--laid bare, but Rothman's report also describes the shameless active collaboration by prominent academic psychiatrists--including the Chairman of the DSM-IV(Dr. Allen Frances, the one who calls psychiatry a "noble profession" - B.M. ) .The prominent academic psychiatrists who were paid by Johnson & Johnson to formulate the Tri-University Guidelines are: Dr. Allen Frances, Chairman of the Dept. of Psychiatry, Duke University; Dr. John P. Doherty, Professor and Vice Chairman of Psychiatry, Cornell University; and David A Kahn, Associate Clinical Professor of Psychiatry, Columbia University; who took the lead in designing and developing the Tri-University Guidelines as a marketing strategy designed to elevate their then new so-called, Atypical Antipsychotic, Risperdal, to first-line treatment.
The report describes how these prominent psychiatrists developed commercially driven prescribing algorithms that they helped masquerade as legitimate, science-based medication prescribing guidelines.
"Not only were Frances, Doherty, and Kahn ready to violate standards of conflicts of interest in mixing guideline preparation with marketing for J&J, but also in publicizing the guidelines in coordination with J&J. The three men established Expert Knowledge Systems [EKS]. The purpose of this organization was to use J&J money to market the guidelines and bring financial benefits to Frances, Docherty, and Kahn.
Dr. Rothman's report states that the 1995 Tri-University Schizophrenia Practice Guidelines was the first of subsequent psychotropic drug prescribing guidelines formulated by prominent academic psychiatrists at the behest of Johnson & Johnson. The best known of these Guidelines was the Texas Medication Algorithm Project (TMAP), which adopted the Tri-University Guidelines en masse.Excerpt describing the inception of the Tri-University Guidelines, page 14: [link]
"As one of its first activities, and in disregard of professional medical ethics of principles of conflict of interest, in 1995 J&J funded a project led by three psychiatrists at three medical centers [Duke, Cornell, and Columbia] to formulate Schizophrenia Practice Guidlines. From the start, the project subverted scientific integrity, appearing to be a purely scientific venture when it was at its core, a marketing venture for Risperdal. In fact, the guidelines produced by this project would become the basis for the TMAP algorithms, giving a market edge to the J&J products in Texas.
Vera Hassner Sharav
(Emphasis in red added - B.M.)